IGC Pharma, Inc. (NASDAQ:IGC) | WebDisclosure

Basculer en Français

10381	Companies
216535	Keywords
146230	Articles
114645	Press releases

Home
Companies
IGC Pharma, Inc.

PRESS RELEASE

published on 11/14/2024 at 14:30, 1 year 5 months ago

IGC Pharma Reports Second Quarter Fiscal 2025 Results, Showcasing Progress in Its Alzheimer’s Pipeline
IGC Pharma, Inc. announces Q2 FY2025 financial results and strategic advancements including breakthroughs in Alzheimer's treatment pipeline. Revenue grows 42% to $412k. R&D expenses decrease 28%

Financial Results R&D Expenses Q2 FY2025 IGC Pharma Alzheimer's Treatment
BRIEF

published on 11/06/2024 at 14:35, 1 year 6 months ago

IGC Pharma met en avant des avancées stratégiques dans les thérapies contre la maladie d'Alzheimer et la perte de poids

Intelligence Artificielle Perte De Poids Agonistes Du GLP-1 IGC Pharma Traitement De La Maladie D'Alzheimer
BRIEF

published on 11/06/2024 at 14:35, 1 year 6 months ago

IGC Pharma Highlights Strategic Advances in Alzheimer's and Weight Loss Therapies

Weight Loss Artificial Intelligence GLP-1 Agonists IGC Pharma Alzheimer's Treatment
PRESS RELEASE

published on 11/06/2024 at 14:30, 1 year 6 months ago

IGC Pharma Announces Publication of IMS Spotlight Interview Highlighting Strategic Expansion in Alzheimer’s and Weight Loss Therapies
IGC Pharma, Inc. (NYSE American: IGC) announces a new interview with CEO Ram Mukunda discussing strategic expansion into metabolic and neurological markets, focusing on Alzheimer's and weight loss therapies, leveraging AI for diverse pipeline

Interview Neurodegenerative Disorders Metabolic Disorders IGC Pharma Ram Mukunda
BRIEF

published on 10/17/2024 at 14:35, 1 year 6 months ago

IGC Pharma étend son essai sur la maladie d'Alzheimer au Canada grâce à un partenariat avec Baycrest

IGC Pharma IGC-AD1 Essai Sur La Maladie D'Alzheimer Partenariat Baycrest Phase 2 Clinique
BRIEF

published on 10/17/2024 at 14:35, 1 year 6 months ago

IGC Pharma Expands Alzheimer's Trial to Canada with Baycrest Partnership

IGC Pharma Alzheimer's Trial IGC-AD1 Baycrest Partnership Phase 2 Clinical
PRESS RELEASE

published on 10/17/2024 at 14:30, 1 year 6 months ago

IGC Pharma Announces Patient Enrollment at Toronto's Baycrest in Phase 2 Trial Investigating IGC-AD1
IGC Pharma expands Phase 2 trial to Canada at Baycrest Academy for Research and Education in Toronto, Ontario, to investigate IGC-AD1 for treating agitation in Alzheimer's dementia

Phase 2 Trial Alzheimer's IGC Pharma Agitation Treatment Baycrest Academy
BRIEF

published on 10/03/2024 at 15:05, 1 year 7 months ago

IGC Pharma Secures Two Awards in NIH's AI PREPARE Challenge

AI Technology Healthcare Innovation IGC Pharma Alzheimer's Prediction NIH Challenge
BRIEF

published on 10/03/2024 at 15:05, 1 year 7 months ago

IGC Pharma remporte deux prix lors du concours AI PREPARE Challenge du NIH

Technologie De L'IA Innovation Dans Le Domaine De La Santé IGC Pharma Prédiction De La Maladie D'Alzheimer Défi Du NIH
PRESS RELEASE

published on 10/03/2024 at 15:00, 1 year 7 months ago

IGC Pharma Wins 2 Prizes in Phase 1 of National Institutes of Health's AI PREPARE Challenge
IGC Pharma, Inc. wins 2 awards in the PREPARE Challenge for Alzheimer's research with its MHAS entry. Recognition highlights leadership in AI for disease prediction

Artificial Intelligence Healthcare Innovation Alzheimer's Research IGC Pharma PREPARE Challenge

Accesswire

Published on 05/11/2026 at 19:55, 1 hour 19 minutes ago

Lithium South Announces Pay Out of Common Shares and Closing of Plan of Arrangement
Published on 05/11/2026 at 19:30, 1 hour 44 minutes ago

Taranis Adjusts Thor Exploration Program Due to Current Political and Regulatory Conditions in British Columbia
Published on 05/11/2026 at 14:30, 6 hours 44 minutes ago

Recent Hantavirus On A Cruise Ship Highlights the Need for Broad-Spectrum Antiviral Drugs Such as NV-387, Says NanoViricides
Published on 05/11/2026 at 14:00, 7 hours 14 minutes ago

Unusual Machines Accelerates Domestic Battery Manufacturing by Signing a Merger Agreement to Acquire Upgrade Energy
Published on 05/11/2026 at 14:00, 7 hours 14 minutes ago

New Horizon Aircraft Ltd. Announces Closing of $20 Million Offering of Common Shares

View all ACCESSWIRE

EQS Group

Published on 05/11/2026 at 20:42, 31 minutes ago

Grand City Properties S.A. proposes Dividend Payment combined with Dividend Policy Update
Published on 05/11/2026 at 20:40, 34 minutes ago

EQS-Adhoc: Grand City Properties S.A. proposes Dividend Payment combined with Dividend Policy Update
Published on 05/11/2026 at 19:28, 1 hour 45 minutes ago

Fuller, Smith & Turner PLC: Transaction in own shares
Published on 05/11/2026 at 19:17, 1 hour 57 minutes ago

Position of Commerzbank on UniCredit’s offer
Published on 05/11/2026 at 19:15, 1 hour 59 minutes ago

Wings for Life World Run 2026 Raises Record €9.2 Million for Spinal Cord Injury Research

Les Echos

Published on 05/11/2026 at 19:02, 2 hours 11 minutes ago

260511 BENETEAU Transactions sur actions propres
Published on 05/11/2026 at 18:18, 2 hours 56 minutes ago

Reporting on share buyback transactions carried out between May 4 and May 5, 2026
Published on 05/11/2026 at 18:18, 2 hours 56 minutes ago

Déclaration de rachats d'actions effectués par la Compagnie de Saint-Gobain les 4 et 5 mai 2026
Published on 05/11/2026 at 18:14, 2 hours 59 minutes ago

Nombre total d'actions et droits de vote - avril 2026
Published on 05/11/2026 at 18:14, 2 hours 59 minutes ago

Number of shares and voting rights - April 2026 (In French only)

View all LES ECHOS COMFI WIRE